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The  term  vaccine  hesitancy  refers  to delay  in  acceptance  or refusal  of vaccines  despite  the  availability  of
vaccination  services.  Different  factors  inﬂuence  vaccine  hesitancy  and  these  are  context-speciﬁc,  varying
across time  and place  and  with  different  vaccines.  Factors  such  as complacency,  convenience  and  conﬁ-
dence  are  involved.  Acceptance  of vaccines  may  be  decreasing  and  several  explanations  for  this  trend  have
been proposed.  The  WHO  Strategic  Advisory  Group  of  Experts  (SAGE)  on Immunization  has  recognized
the  global  importance  of vaccine  hesitancy  and  recommended  an interview  study  with  immunization
managers  (IMs)  to  better understand  the  range  of  vaccine  hesitancy  determinants  that  are encountered
in  different  settings.  Interviews  with  IMs  in 13  selected  countries  were  conducted  between  September
and  December  2013  and  various  factors  that discourage  vaccine  acceptance  were  identiﬁed.  Vaccine  hes-eterminants
accination
nterviews
mmunization managers
itancy  was  not  deﬁned  consistently  by  the IMs  and  most  interpreted  the  term  as  meaning  vaccine  refusal.
Although  vaccine  hesitancy  existed  in  all 13  countries,  some  IMs  considered  its  impact  on immunization
programmes  to  be a  minor  problem.  The  causes  of vaccine  hesitancy  varied  in the different  countries  and
were context-speciﬁc,  indicating  a need  to strengthen  the capacity  of  national  programmes  to  identify
the  locally  relevant  causal  factors  and  to  develop  adapted  strategies  to address  them.
©  2014  The  Authors.  Published  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-ND. Introduction
Attitudes to vaccination can be seen as a continuum ran-
ing from total acceptance to complete refusal. Vaccine-hesitant
ndividuals are a heterogeneous group within this continuum.
accine-hesitant individuals may  refuse some vaccines, but agree
o others, delay vaccination or accept vaccination although doubt-
ul about doing so [1,2]. Vaccine hesitancy is present when vaccine
cceptance is lower than would be expected in the context of infor-
ation provided and the services available. The phenomenon is
omplex and context-speciﬁc, varying across time and place and
ith different vaccines. Factors such as complacency, convenience,
s well as conﬁdence in vaccines(s) may  all contribute to the delay
f vaccination or refusal of one, some or almost all vaccines [3].The WHO  Strategic Advisory Group of Experts (SAGE) on
mmunization has recognized the global importance of vaccine
esitancy as a growing problem. The SAGE Working Group on
∗ Corresponding author.
E-mail address: SchusterM@who.int (M.  Schuster).
ttp://dx.doi.org/10.1016/j.vaccine.2014.09.039
264-410X/© 2014 The Authors. Published by Elsevier Ltd. This is an open access article unlicense  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Vaccine Hesitancy was  set up with the mandate to examine the
evidence and provide advice to SAGE on how to address vaccine
hesitancy and its determinants [4].
In order to map  the inﬂuential contributing factors, the SAGE
Working Group developed a matrix of determinants of vaccine
hesitancy based on a systematic literature review [5]. This matrix
acknowledges the scope of vaccine hesitancy, and differentiates
between contextual, individual, group, and vaccine- or vaccination-
speciﬁc factors that inﬂuence the acceptability for vaccination [6].
In April 2013, SAGE recommended that interviews be con-
ducted with immunization managers (IMs) [7], who have oversight
responsibility at state and national levels for an immunization pro-
gramme, in order to better understand the variety of challenges
existing in different settings [3,8].
This paper reports the results of the interviews conducted
between September and December 2013.2. Methods
The SAGE Working Group developed a guide for the conduct
of telephone-based interviews, designed for qualitative capture of
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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nanticipated responses and assessment of known determinants
f vaccine hesitancy. Data were collected using semi-structured
nterviews [9,10].
To obtain a representative sample of countries with a broad
ange of socioeconomic settings and population sizes over all
egions, a purposive sampling technique was used. Criteria for
election included:
i. Representation from all six WHO  Regions–—African (AFR),
Americas (AMR), Eastern Mediterranean (EMR), European
(EUR), South-East Asia (SEAR) and Western Paciﬁc (WPR).
ii. Representation from the three economic categories recognized
by the World Bank—low, middle and high income countries [11].
ii. The national IM had to be experienced and responsive.
In consultation with WHO  regional advisors on immunization,
5 countries were selected that together met  the range of criteria.
he IMs  from each of the selected countries were contacted and
riefed by staff from the WHO  regional ofﬁces. Interviews were
onducted in English, Spanish or French by two interviewers from
HO.
The interviews were recorded and summarized by the inter-
iewers. Interview transcriptions were sent back to the IMs  for
eview, correction if necessary, and approval. A structured elec-
ronic data extraction form was developed with predeﬁned data
elds for extracting consistent data. For all interviews, data were
xtracted and entered by two independent researchers. A third
ndependent senior researcher checked for accuracy and complete-
ess of the two  datasets. Data were analysed by question and
apped against matrix of determinants [6].
. Results
Interviews were completed with 13 IMs  from the six WHO
egions: one from AMR  (Panama), two from AFR (Republic of the
ongo, Zimbabwe), two from EMR  (Saudi Arabia, Yemen), three
rom EUR (Armenia, Belgium, Montenegro, one from SEAR (India),
nd four from WPR  (Japan, Lao PDR, Malaysia, Philippines); most
epresented low and middle income countries (n = 11). Interviews
asted on average 30 min.
.1. Deﬁnition of vaccine hesitancy
Four IMs  explicitly deﬁned their understanding of vaccine hes-
tancy, as follows: (i) those persons resisting to get vaccinated
ue to various reasons (Country K); (ii) someone who  does not
elieve vaccines are working and are effective and that vaccines
re not necessary (Country F); (iii) parents who would not allow
mmunization of their child and policy makers who hesitate to
ntroduce a vaccine especially in regard to new vaccinesvs other
xisting public health interventions (Country L); (iv) an issue that
hould be addressed when reaching 90% vaccination coverage
Country C). Although the views of other IMs  regarding vaccine
esitancy were less explicit, most associated vaccine hesitancy
ith parental refusal of one or more vaccines (n = 9). Vaccination
elays were not included in the deﬁnition of vaccine hesitancy
y IMs, except in one country, where the IM stated: There is
ot a problem with under-vaccinated or unimmunized. There
re issues with timely vaccination—with following the schedule.
arents are delaying the vaccinations (Country F). Table 1 summa-
izes the opinions of the IMs  regarding vaccine hesitancy in their
ountries. (2014) 6649–6654
3.2. Impact of vaccine hesitancy on the country’s immunization
programme
At the time of the interview, all except one IM had heard
reports of people reluctant to accept one or all vaccines in their
country (Table 2). In the country where no such reports had
been heard, the problem reported was vaccine refusal for rea-
sons related to religious beliefs, not hesitancy. In another country,
the IM had not heard of any reports of vaccine hesitancy, but
acknowledged that a small proportion of the whole population had
some concerns regarding vaccine safety and could be considered as
vaccine-hesitant. In several countries, IMs  reported current or past
difﬁculties due to lack of acceptance related to one speciﬁc vaccine
or to speciﬁc combinations of vaccines (e.g. HPV or TT).
Even if there had been reports of vaccine hesitancy in their
country, 11 of the 13 IMs  considered that vaccine hesitancy was
not common and that it did not have a signiﬁcant impact on vac-
cine uptake in the routine immunization programmes. IMs from
two countries indicated that mass immunization campaigns, rather
than routine immunization programmes, were affected by vaccine
hesitancy. However, two IMs  stated that vaccine hesitancy was an
important issue in their country.
When IMs  were asked about the percentage of non-vaccinated
and under-vaccinated individuals in their country due to lack of
conﬁdence in vaccination, only six provided estimates ranging from
less than 1% to 20% (Table 2).
Four IMs  reported issues of complacency in their countries
(Table 2). As an example, one IM cited a particular indigenous group
which had refused vaccination because vaccination programme
activities coincided with a cultural event. Four IMs  stated that
complacency was not a problem in their countries because immu-
nization was  perceived as a priority by most of the population.
Factors concerning convenience and ease of access were
perceived to be important by nine of the IMs  (Table 2). Convenience
was a factor for sub-populations which did not use the health ser-
vices provided and for hard-to-reach populations. For instance, in
one country, more than 25% of the population had no access to
health services and access was  difﬁcult for immigrants, refugees,
nomad populations, those living in remote areas, and for women
(mainly because of the socio-norms that require them be accom-
panied for travel to obtain health care).
3.3. Determinants of vaccine hesitancy using the Working Group
matrix
Fig. 1 summarizes the opinions of IMs  regarding the main deter-
minants of vaccine hesitancy in the Working Group matrix.
3.3.1. Contextual inﬂuences
Religious beliefs were often a causal factor in vaccine hesi-
tancy (cited by nine IMs). Several IMs  were able to speciﬁcally
identify religious groups in their country that were known to be
opposed to all vaccines, while others discussed “religious reasons”
without specifying a religion or a group. Religious beliefs were usu-
ally linked to refusal of all vaccines, except in one country, where
there were speciﬁc problems of acceptance of the HPV  vaccine
among Catholic groups. Other groups in which vaccine hesitancy
was encountered included ethnic or indigenous groups, people of
higher socioeconomic status, well-educated people and people liv-
ing in urban areas. One IM indicated that the older generation was
more hesitant than the younger generation, and another found that
women were more hesitant than men.
The actual problem is vaccine refusal due to religious beliefs.
This religion is apostolic. They are reluctant to bring their children
to the hospital [for immunization] (Country B).
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Table  1
Summary of immunization managers’ opinions on vaccine hesitancy.
Countries Immunization managers’ perspective on vaccine hesitancy in their country
A Vaccine hesitancy is mostly associated with mass immunization campaigns, especially against polio. It is seen mainly in large cities and associated
with  particular religious groups. Routine immunization programs are not affected by vaccine hesitancy and access is the main issue.
B  Vaccine hesitancy is not considered a problem in the country. Instead, there is vaccine refusal, which is associated with religious groups and higher
socioeconomic status. However, vaccine refusal is also not considered a major problem.
C  Vaccine hesitancy is not considered a major issue in the country. However, there is a small proportion of the whole population who has concerns
about  the safety of vaccines and could be categorized as vaccine-hesitant. This is mostly related to the new and costly vaccines, such as the
pentavalent vaccine and is seen mainly in the well-educated population group. There are no issues of complacency or convenience (except for
migrant populations). Vaccine hesitancy is not considered to have a signiﬁcant impact on overall coverage rates.
D  Vaccine hesitancy is not an issue in the country. Vaccine hesitancy is limited to illegal settlers.
E  Although political conﬂict and instability negatively affect overall access to health services, vaccine hesitancy is not a major issue in the country.
Some  negative rumours about vaccination have circulated in speciﬁc regions and groups of people. Access to vaccination services is challenging for
women  and nomads.
F Vaccine hesitancy is not a major issue in the country and most children are fully immunized by the age of two. Vaccine hesitancy is mainly associated
with  medical academics and health care workers who  do not believe vaccines are safe and effective (especially combination vaccines and vaccines
produced in developing countries). Additionally, there have been issues with religious groups being advised against vaccines because it is forbidden
by  their religion as well as concerns regarding the safety of combination vaccines.
G  In the country, vaccine hesitancy leading to vaccine refusal is not very frequent and is rather localized. Vaccine hesitancy issues have come up in
particular groups such as anthroposophist schools, the orthodox Jewish community and Roma societies. Complacency and access to certain
communities are bigger issues than hesitancy.
H  Vaccine hesitancy exists but is not a major issue in the country. It is not linked to particular groups or geographic areas. Vaccine hesitancy is
associated with a lack of perceived beneﬁt of vaccination due to low prevalence of vaccine-preventable disease in the country. There are also concerns
regarding vaccine safety and the negative inﬂuence of “Internet stories”.
I  There are two major groups hesitant to get vaccinated: (1) a small minority of religious groups who  do not believe in the beneﬁt of vaccines due to
religious or philosophical reasons and (2) the general public concerned by adverse events following immunization (AEFI). Vaccine hesitancy is
associated with speciﬁc vaccines being in “the focus of attention” (such as HPV or OPV). Media reports of rare adverse events make parents hesitant to
vaccinate their children, resulting in decreased uptake. While access and complacency are not important issues, it is speculated that vaccine hesitancy
could  explain up to 30% of the decrease observed in OPV vaccine coverage (prior to IPV introduction).
J  Vaccine hesitancy is an important issue in the country. Vaccine hesitancy is associated with particular ethnic minorities (ethnic Hmong) and remote
communities, with a particular focus on the education level of the local population in remote communities. Vaccine hesitancy is associated with lack
of  perceived beneﬁts of immunization and negative beliefs based on myths (such as vaccination of women leading to infertility).
K  Vaccine hesitancy exists in the country, but is rather small. Vaccine hesitancy is mostly associated with people of high socio-economic status living in
urban areas who have concerns regarding vaccine safety (especially thimerosal containing vaccines). Concerns regarding porcine components in
vaccines by Muslim populations also contribute to vaccine hesitancy in the country.
L  Vaccine hesitancy is mostly related to mass immunization campaigns against tetanus. As a result of vaccine hesitancy due to concerns with vaccine
safety,  up to 20% of eligible population is un- or under-vaccinated. Serious AEFI-inﬂammation at the site of injection and Catholic pro-life groups
stating that TT vaccination was resulting in abortion or infertility have contributed to vaccine hesitancy regarding TT vaccination. Routine vaccination
programs are not affected by vaccine hesitancy.
M Vaccine hesitancy is not an important issue in the country and the immunization program has a positive image. However, vaccine hesitancy did occur
in  particular situations and populations. For example, vaccine hesitancy originated from the Catholic Church when HPV  vaccine was  introduced, and
from  health-care professionals when inﬂuenza vaccine and TDaP were recommended to be administered to pregnant women. Vaccine hesitancy also
occurred among indigenous groups. Additionally, there are vaccine refusals among indigenous groups when vaccination week coincides with cultural
events. Geographic barriers may  limit the percent vaccinated in some remote areas, but is not linked with vaccine hesitancy. There are no
anti-vaccine groups in the country and there is not much vaccine refusal.
Table 2
Summary of vaccine hesitancy issues in countries.
Countries
A B C D E F G H I J K L M
Have you heard reports of people
hesitating around whether or not to
accept one or all vaccine(s) in your
country?
Y N Y Y Y Y Y Y Y Y Y Y Y
Does  vaccine hesitancy impact on the
immunization program?
N N N N N N N N Y Y N N N
Do  you have an estimate of the % of
un- and under-vaccinated in whom
lack of conﬁdence was  a factor that
inﬂuenced their decision to get
immunized?
UN 10% (ES) <5% (ES) <1% (ES) UN UNK UN UNK 30%a (ME) 30%b (ES) <5% (ES) 20%c (ES) UNK
Is  complacency a problem in some
subpopulations?
UN Y N N UN N Y Y N Y N N N
Are  there subpopulations where
convenience is a barrier to
immunization?
Y Y Y Y Y N Y N N Y N Y Y
Y: Yes; N: No; UN: Unanswered; UNK: Unknown; ES: Estimated; ME:  Measured.
a Only for OPV vaccine.
b In a speciﬁcally sub-population.
c 8% of vaccine refusal, measured.
6652 E. Dubé et al. / Vaccine 32 (2014) 6649–6654
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The role of inﬂuential leaders in increasing vaccine hesitancy
mong the population was noted by six IMs. These leaders were
ssociated with anti-vaccination groups, religious groups or health
rofessional groups.
A Catholic pro-life group started the rumour that the TT adminis-
ered to pregnant women only contained a contraceptive hormone
hat stimulates the body to produce antibodies that results to abor-
ion or allegedly infertility in women (Country L).
Causes of vaccine hesitancy linked to the “communication and
edia environment” were identiﬁed by ﬁve IMs. Two  IMs  spoke
roadly about “rumours and misconceptions” regarding vacci-
ation circulating in their country and three directly identiﬁed
egative information conveyed in the mass media (television and
nternet) as causes of vaccine hesitancy.
The second important thing is all the internet stories. The inter-
et is a useful thing for everybody, even for us, it is much easier to
et information, but not always appropriate information. And there
re a lot of stories about adverse events following immunization
Country H).
Geographic barriers were identiﬁed by six IMs  as factors in
educing access to vaccination services, but the association with
accine hesitancy was not clear. In one country, political conﬂicts
nd instability leading to poverty, internal population displace-
ents and insecurity, could partially explain vaccine hesitancy.
It is easier to mobilize the vaccination team than the population,
ho are only coming little by little to the clinic. The problem of
istance is the programs responsibility (Country M).
Finally, in one country, vaccine hesitancy was seen mainly
mong illegal settlers or immigrants without an ofﬁcial status.
hese individuals hesitated to use health services because of fear of
eing reported to the police, even though the Expanded Programme
n Immunization (EPI) offers immunization with permission from
he government.ding determinants of vaccine hesitancy*.
The main reason for vaccine hesitancy is living illegally in the
country so that theydo not seek or beneﬁt from EPI service at Public
Health Clinic in order not to be reported to police (Country D).
3.3.2. Individual and group inﬂuences
Three main determinants of vaccine hesitancy pertaining to
individual and group inﬂuences were identiﬁed.
Risk perceptions were identiﬁed by seven IMs  as causal factors.
This included concerns regarding vaccine safety, lack of perceived
beneﬁts of vaccination and lack of understanding of the burden of
vaccine-preventable diseases.
The new vaccine that we  have recently introduced in the country
was the DTap, Hepatitis B, Hib-containing pentavalent vaccine and
concerns were raised around the safety of this combined vaccine
(Country C).
There were certain groups that were very concerned about
the safety of vaccines, in particular thimerosal-containing vaccines
(Country K).
People’s level of trust in the health system and health-care
providers was  identiﬁed by four IMs  as a causal factor. One noted
that the way  people were treated in the health services could dis-
courage them from returning, while another highlighted the fact
that some religious groups were reluctant to bring their children
to the hospital. In one country, women  prefer to receive care from
female providers, who  are scarce in that country, and this could at
least partially explain the lack of vaccination among women.
Women  ﬁnd it more difﬁcult to access services, mainly because
of the socio-norms that they need somebody to travel with them
if they need to get health care. And they like to be seen by female
health-care providers, who  are not available in many health facil-
ities, neither in sufﬁcient number, nor with needed qualiﬁcations
(Country E).
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Lack of knowledge (or misinformation) in the population
egarding vaccination was identiﬁed by four IMs  as a contributing
actor in vaccine hesitancy.
Reasons for this are that they are not properly informed or have
ever following vaccination. These non-serious adverse events after
mmunization are misperceived by the population (Country C).
Further the families, in particular the fathers, need to be edu-
ated about the adverse events following immunization as they
rohibit the mothers going back to the health clinic for consecutive
oses if the child develops mild fever after vaccination (Country J).
.3.3. Vaccine- and vaccination-speciﬁc factors
Risk of adverse events following vaccination was identiﬁed by
hree IMs  as contributing to vaccine hesitancy.
Vaccine hesitancy is related to the report on the cluster of
dverse events after immunization, inﬂammation at the site of
njections. Investigation was done and immunization safety prac-
ices were strengthened and information dissemination on the
afety of the vaccine was intensiﬁed. However, major vaccine hes-
tancy was still related to the vaccine (Country L).
The design of the vaccination programme was  identiﬁed as a
ontributory factor by three IMs. In two countries, vaccine hes-
tancy was related to mass vaccination programmes but not to
outine immunization programmes. In the other country, members
f a religious group were refusing to bring their children to the hos-
ital or health centres for immunization but agreed to have them
mmunized if offered at home.
They made seven mass vaccination campaigns in the past and
hat caused a lot of problems. Particularly, vaccine hesitancy was
bserved during those mass campaigns (. . .). Routine immuniza-
ion was not affected by vaccine hesitancy (Country A).
Lack of knowledge about vaccination among health profession-
ls was speciﬁed by two IMs  as being linked to vaccine hesitancy
n the population.
The lack of knowledge of their own doctors who are not updated
nd are not familiar with the updated information. Understanding
eads to a change in attitude. If they [the doctors] do not have the
pdated information they will continue with the teachings of the
ld school (Country M).
Reliability of the vaccine supply was also noted as a difﬁculty in
ne country; because vaccines were out of stock, vaccination series
ere not completed. In another country, the provenance of the vac-
ines was linked to vaccine hesitancy; there was  distrust of vaccines
roduced in developing countries (India and Indonesia) caused vac-
ine hesitancy among health-care workers who would prefer to use
accines produced in Europe. In two countries, IMs  noted that there
ere concerns among the Muslim population due to suspected use
f porcine components in vaccines. Finally, introduction of new vac-
ines or new indications was perceived (more or less explicitly) as
ontributing to vaccine hesitancy in four countries. In one country,
he introduction of new and costly vaccines was  seen as triggering
accine hesitancy.
The country will soon introduce PCV, and this may  be a new
eason for people to hesitate and for those who do not believe in
accines to voice their opinions and be active against vaccination
Country F).
. Discussion
This study revealed a number of challenges concerning vaccine
esitancy, starting with discrepancies in how the term was under-
tood and interpreted by IMs. It was not consistently deﬁned and
everal IMs  interpreted it, explicitly or implicitly, as limited only
o vaccine refusal. Several noted stock outs as a cause. Yet the
eﬁnition developed by the Working Group speciﬁes that vaccine (2014) 6649–6654 6653
hesitancy refers to delay in acceptance or refusal of vaccines despite
availability of vaccine services. This indicates that the proposed def-
inition, while broad and inclusive, will need to be promoted among
IMs  if vaccine hesitancy is to be comparably assessed in different
settings
Some IMs  considered the impact of vaccine hesitancy on immu-
nization programmes to be a minor problem, possibly due to their
interpretation of the terminology. The ﬁndings when questioned
about lack of conﬁdence in vaccination well illustrate the problem.
The IMs  all struggled when asked to provide an estimate of the
percentage of non-vaccinated and under-vaccinated individuals in
their countries for whom lack of conﬁdence was a factor. This could
be related to difﬁculty in quantifying such a variable and/or to lack
of clarity and understanding of the term “lack of conﬁdence” in this
context.
The ﬁndings show that vaccine hesitancy was not restricted to
any speciﬁc region or continent but exists worldwide. While some
IMs  considered the impact of vaccine hesitancy on immunization
programmes to be a minor problem in their country, for others it
was more serious. Although some IMs  associated vaccine hesitancy
with particular religious or ethnic groups, most agreed that vaccine
hesitancy is not limited to speciﬁc communities, and exists across
all socioeconomic strata of the population. Some IMs  associated
it with highly educated individuals, which is in agreement with
previous studies in different settings showing that non-compliant
individuals often appear to be well-informed people who  have
considerable interest in health-related issues and actively seek
information [12,13]. Two IMs  emphasized that health professionals
may  themselves be vaccine-hesitant. This is of particular concern as
health professionals’ knowledge and attitudes about vaccines have
been shown to be an important determinant of their own vaccine
uptake, their intention to recommend vaccines to their patients,
and the vaccine uptake of their patients [14–17].
The observation that vaccine hesitancy is not uniform through-
out the country reveals another challenge. IMs  may  need not only to
carry out a country assessment of hesitancy, but also a subnational
and even a district level assessment, to fully understand the extent
of the phenomenon within a country. This will be particularly
important when planning for supplementary immunization activi-
ties, surveys, or speciﬁc campaigns to catch up the non-vaccinated
or under-vaccinated, for which vaccine-hesitant persons could be
selected as a speciﬁc target group.
Overall, the ﬁndings ﬁt well within the matrix of determinants
of vaccine hesitancy developed by the SAGE Working Group and
no additional determinants were identiﬁed. The IMs  noted vari-
able and context-speciﬁc causes of vaccine hesitancy. Conﬁdence,
complacency and/or conﬁdence issues were all raised during the
interviews. Frequently identiﬁed determinants included concerns
regarding vaccine safety, sometimes due to scientiﬁcally proven
adverse events after vaccination or else triggered by rumours, mis-
conceptions or negative stories conveyed in the media. Religious
beliefs and the inﬂuence of religious leaders was  another frequently
identiﬁed determinant; refusal of some or all vaccines among
some religious communities has been well-documented [18,19].
The inﬂuence of communication and media, lack of knowledge or
education, and the mode of vaccine delivery (i.e. mass vaccination
campaigns) were other determinants identiﬁed by IMs. In low and
middle income countries, causal factors included geographic bar-
riers to vaccination services, political conﬂicts and instability, and
illegal immigration.
This study is the ﬁrst to report on how IMs  understand and inter-
pret the term vaccine hesitancy and has provided useful insights on
the current situation in different countries and settings, showing
the variability in manifestation of vaccine hesitancy and its impact
on immunization programmes. However, the results should be con-
sidered in light of some limitations. The countries were selected by
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HO  in order to represent a diversity of regions and situations, but
t was difﬁcult to obtain the participation of some countries. Two
Ms  could not participate for different reasons. Most interviews
ere conducted in English and this may  have been challenging
or non-English speakers, resulting in information bias. Interviews
ere loosely conducted and some questions were not posed to
very IM.  As with any qualitative study, desirability bias cannot
e excluded, nor can the ﬁndings be extrapolated to all countries.
t should be noted that the country-speciﬁc situation was  reported
y a single IM,  essentially based on his/her own opinions and esti-
ations. Although IMs  are generally very well-informed on issues
urrounding vaccination, it is thus very possible that different views
ight have been expressed if another informant had been inter-
iewed in the same country. Finally, although most of the research
n vaccine hesitancy is conducted in high income countries [5],
he majority of IMs  interviewed in this study were from low and
iddle income countries. Indeed, the results could have differed
f more IMs  from high income countries had been interviewed, as
hey may  be more aware of vaccine hesitancy and its determinants
ecause this ﬁeld of research is more developed in those countries.
he choice of countries also limited the possibility of assessing dif-
erences in the perspective of IMs  between regions and economic
ategories.
To conclude, understanding the speciﬁc concerns of the various
roups of vaccine-hesitant individuals, including health profession-
ls, is important as hesitancy may  result in vaccination delays or
efusals. Vaccine hesitancy is an individual behaviour, but is also the
esult of broader societal inﬂuences and should always be looked
t in the historical, political and socio-cultural context in which
accination takes place. The results of this study will be used by
he SAGE Working Group on vaccine hesitancy in preparing its
ecommendations to the SAGE, which will then consider potential
lobal health policy implications. The ﬁndings highlight the need to
nsure that health professionals and those involved in immuniza-
ion programmes are well informed about vaccine hesitancy and
re able to identify and address its determinants. There is a need to
trengthen the capacity of countries to identify the context-speciﬁc
oots of vaccine hesitancy and to develop adapted strategies to
ddress them.
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